The Biologics News and Reports Portal

Show Cart

Therapeutic Proteins & Peptides

Results 1 - 10 of 17

Dec 2014 Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

1,935.00 €

2,150.00 €

(Discount: 10.00%)

Jul 2014 Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders

1,462.50 €

1,950.00 €

(Discount: 25.00%)

Jul 2014 Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors

200.00 €

Jun 2013 Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares

2,150.00 €

Start
Prev
1
2
Next
End

Shopping cart

Cart empty

Latest report

Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Featured Products

Report Package: “Drug the Undruggable” Technologies

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

Latest Target Pipeline

STING Agonists & Antagonists

Shopping cart

Cart empty

Latest report

Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Featured Products

Report Package: “Drug the Undruggable” Technologies

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

Therapeutic Proteins & Peptides

Dec 2014 Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

Nov 2014 Competitor Analysis: Cancer Peptides

Nov 2014 Competitor Analysis: Cardiometabolic Peptides

Oct 2014 Competitor Analysis: Anti-Infective Peptides

Oct 2014 Competitor Analysis: Cardiovascular Peptides

Sep 2014 Competitor Analysis: Anti-Inflammatory Peptides

Aug 2014 Competitor Analysis: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Jul 2014 Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders

Jul 2014 Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors

Jun 2013 Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing